Skip to main content

Urgo patient

UrgoStart Plus range banner

UrgoStart Plus Treatment Range

The UrgoStart Plus treatment range is developed to provide continuous debridement and effectively close wounds sooner in patients with comorbidities who are at risk of delayed healing.

The technology behind UrgoStart Plus range of wound dressings:

UrgoStart Plus: TLC-NOSF
Technology Lipido-Colloid NOSF (TLC-NOSF) +
Magnet Fibres Magnet Fibres Technology

The UrgoStart Plus range combines TLC-NOSF with polyabsorbent fibres (Magnet Fibres technology) to provide effective healing with continuous debridement of slough and exudate to keep wounds clean.4

Continuously Debrides4,5

Continuously Debrides

Polyabsorbent fibres trap slough and keep the wound clean

You can use one simple treatment on all tissue types: sloughy, granulating and epithelising wounds

Effectively Heals1,2

effectively Heals

Healing matrix reduces MMP levels and restores balance

Restores balance to the patient’s healing trajectory

Closes Sooner1,2,3

closes Sooner

Closes wounds sooner than other dressings

The sooner you implement it, the better the outcomes

Key benefits of UrgoStart Plus range of wound dressings

Our UrgoStart Plus dressings can be beneficial for wound care in the following ways:

✓
Reduces excess MMPs to restore balance to healing and closes wound sooner.1,2,3
✓
Atraumatic and pain-free removal.5
✓
Continuous debridement to keep wounds clean.4
✓
Recommended by NICE and the first and only dressing recommended by the IWGDF.6,7
✓
Effective, Easy to Use and Evidence-based

Explore the UrgoStart Plus Product Range

UrgoStart Plus Pad

UrgoStart Plus Pad

For low to moderately exuding wounds.

View Product

UrgoStart Plus Absorb

UrgoStart Plus Absorb

For moderately to heavily exuding wounds (non-adhesive format).

View Product

UrgoStart Plus Border

UrgoStart Plus Border

For moderately to heavily exuding wounds (adhesive format).

View Product


Products

UrgoStart Plus Absorb

Take control of healing and cleaning, close wounds sooner Effective, Evidence-B....

UrgoStart Plus Border

Take control of healing and cleaning, close wounds sooner Effective, Evidence-B....

UrgoStart Plus Pad

Take control of healing and cleaning, close wounds sooner Effective, Evidence-B....

Get in Touch with Our Representative for More Information About the UrgoStart Plus Treatment Range

Contact us

References

  1. Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, Martini J, Petit JM, Rayman G, Lobmann R, Uccioli L, Sauvadet A, Bohbot S, Kerihuel JC, Piaggesi A. Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial. Lancet Diabetes Endocrinol. 2018 Mar;6(3):186-196.
  2. Münter KC, Meaume S, Augustin M, Senet P, Kérihuel J.C. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings. J Wound Care. 2017 Feb; 26 (Sup2): S4-S15. Erratum in: J Wound Care. 2017 Mar 2; 26(3): 153.
  3. Lazaro et al . Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer. JWC VOL 28, NO 6, June 2019.
  4. Meaume S, Dissemond J, Addala A. Evaluation of two fibrous wound dressings for the management of leg ulcers: results of a European randomised controlled trial (EARTH RCT). J Wound Care 2014; 23: 3, 105–116.
  5. Schmutz J.L. et al. Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers : results of a randomised, controlled trial. Int Wound J 2008;5:172–182.
  6. National Institute for Health and Care Excellence (NICE), UrgoStart for treating leg ulcers and diabetic foot ulcers, https://www.nice.org.uk/guidance/mtg42, April 2023.
  7. Chen P, Campillo Vilorio N, Dhatariya K et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes. IWGDF 2023 update. Diabetes Metab Res Rev 2024; 40(3):e3644. https://doi.org/10.1002/dmrr.3644.

You are being redirected our of URGO Medical APAC website. The content on the subsequent website is intended for and only applicable to the market’s home audience.

Do you wish to proceed?